维普中文期刊产品整合服务
13篇 您的检索式:作者名="Shetty GS"
    题名 作者 年代 出处 被引量
1Extending the limita- tions of liver surgery: outcomes of initial human expe- rience in a high-volume center performing single-port la- paroscopic liver resection for hepatocellular carcinoma显示文摘Shetty GS You YK Choi I-I J 2012Surg Endosc2012,26,6:1
2Xanthogranulomatous cholecystitis: sonographic and CT features and differentiation from gallbladder carcinoma: a pictorial essay 显示文摘Shetty GS Abbey P Prabhu SM 2012Jpn J Radiol2012,30,6:1
3Is early feeding after major gastrointestinal sugery a fash advance,Evidence-based review of literature显示文摘Shrkhande SV Shetty GS Singh K 2009J Cancer Res Ther2009,5,4:1
4Phenotypic detection of inducible clindamycin resistance among Staphylococcus aureus isolates by using the lower limit of recommended inter-disk distance显示文摘Ajantha GS Kulkarni RD Shetty J 0,,:1
5Extending the limitations of liver surgery: outcomes of initial human experience in a high-volume center performing single-port laparoscopic liver resection for hepatocellular carcinoma显示文摘Shetty GS You YK Choi HJ 2012Surg Endosc2012,26,6:1
6Xanthogranulomatous cholecystitis: sonographic and CT features and differentiation from gallbladder carcinoma: a pictorial essay 显示文摘Shetty GS Abbey P Prabhu SM 2012Jpn J Radiol2012,30,6:1
7Is early feeding after major gastrointestinal surgery a fashion or an advance? Evidence-based re- view of literature 显示文摘Shrikhande SV Shetty GS Singh K 2009J Cancer Res Ther2009,5,4:1
8Xanthogranulomatous chole- cystitis: sonographic and CT features and differentiation from gall- bladder carcinoma : a pictorial essay 显示文摘Shetty GS Abbey P Prabhu SM 2012Jpn J Radio12012,30,:1
9Is early feeding af- ter major gastrointestinal surgery, a fashion or an advance? Evi- dence-based review of literature显示文摘Shrikhande SV Shetty GS Singh K 2009J Cancer Res Ther2009,5,4:1
10Extending the limitations of liver surgery: outcomes of initial human experience in a high-volume center performing single-port laparoscopic liver resection for hepatocellular carcinoma显示文摘Shetty GS You YK Choi HJ 2012Surg Endosc2012,26,6:1
11Synchronous hepatocellular carcinoma with renal cell carcinoma : a case report and review of literature of multiple synchronous primary malignancies 显示文摘Shetty GS Bhalla P Desai SM 2013Indian J Surg2013,75,1:1
12Xanthogranulomatouscholecystitis :sonographic and CT features anddifferentiation from gallbladder carcinoma :a pictorial essay显示文摘Shetty GS Abbey P Prabhu SM et a1 2012Jpn J Radiol2012,30,6:1
13Exosomes: Emerging implementation of nanotechnology for detecting and managing novel corona virus-SARS-CoV-2显示文摘The spread of SARS-CoV-2 as an emerging novel coronavirus disease (COVID-19) had progressed as a worldwide pandemic since the end of 2019. COVID-19 affects firstly lungs tissues which are known for their very slow regeneration. Afterwards, enormous cytokine stimulation occurs in the infected cells immediately after a lung infection which necessitates good management to save patients. Exosomes are extracellular vesicles of nanometric size released by reticulocytes on maturation and are known to mediate intercellular communications. The exosomal cargo serves as biomarkers in diagnosing various diseases;moreover, exosomes could be employed as nanocarriers in drug delivery systems. Exosomes look promising to combat the current pandemic since they contribute to the immune response against several viral pathogens. Many studies have proved the potential of using exosomes either as viral elements or host systems that acquire immune-stimulatory effects and could be used as a vaccine or drug delivery tool. It is essential to stop viral replication, prevent and reverse the massive storm of cytokine that worsens the infected patients’ situations for the management of COVID-19. The main benefits of exosomes could be;no cells will be introduced, no chance of mutation, lack of immunogenicity and the damaged genetic material that could negatively affect the recipient is avoided. Additionally, it was found that exosomes are static with no ability for in vivo reproduction. The current review article discusses the possibilities of using exosomes for detecting novel coronavirus and summarizes state of the art concerning the clinical trials initiated for examining the use of COVID-19 specific T cells derived exosomes and mesenchymal stem cells derived exosomes in managing COVID-19.Akhilesh Dubey Cynthia Lizzie Lobo Ravi GS Amitha Shetty Srinivas Hebbar Sally AEl-Zahaby 2022Asian Journal of Pharmaceutical Sciences2022,17,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费